|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Youlden DR, Cramb SM and Baade PD: The
international epidemiology of lung cancer: Geographical
distribution and secular trends. J Thorac Oncol. 8:819–831. 2008.
View Article : Google Scholar
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mullany LE, Herrick JS, Wolff RK, Stevens
JR, Samowitz W and Slattery ML: MicroRNA-transcription factor
interactions and their combined effect on target gene expression in
colon cancer cases. Genes Chromosomes Cancer. 57:192–202. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fang X, Sastry A, Mih N, Kim D, Tan J,
Yurkovich JT, Lloyd CJ, Gao Y, Yang L and Palsson BO: Global
transcriptional regulatory network for Escherichia coli robustly
connects gene expression to transcription factor activities. Proc
Natl Acad Sci USA. 114:10286–10291. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ruan J, Dean AK and Zhang W: A general
co-expression network-based approach to gene expression analysis:
Comparison and applications. BMC Syst Biol. 4:82010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miller JA, Horvath S and Geschwind DH:
Divergence of human and mouse brain transcriptome highlights
Alzheimer disease pathways. Proc Natl Acad Sci USA.
107:12698–12703. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carlson MR, Zhang B, Fang Z, Mischel PS,
Horvath S and Nelson SF: Gene connectivity, function, and sequence
conservation: Predictions from modular yeast co-expression
networks. BMC Genomics. 7:402006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oldham MC, Konopka G, Iwamoto K,
Langfelder P, Kato T, Horvath S and Geschwind DH: Functional
organization of the transcriptome in human brain. Nat Neurosci.
11:1271–1282. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Udyavar AR, Hoeksema MD, Clark JE, Zou Y,
Tang Z, Li Z, Li M, Chen H, Statnikov A, Shyr Y, et al:
Co-expression network analysis identifies SpleenTyrosine Kinase
(SYK) as a candidate oncogenic driver in a subset of small-cell
lung cancer. BMC Syst Bio. 5 (Suuppl):S12013. View Article : Google Scholar
|
|
11
|
Tian F, Zhao J, Fan X and Kang Z: Weighted
gene co-expression network analysis in identification of
metastasis-related genes of lung squamous cell carcinoma based on
the Cancer Genome Atlas database. J Thorac Dis. 9:42–53. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gou Y and Xing Y: Weighted gene
co-expression network analysis of pneumocytes under exposure to a
carcinogenic dose of chloroprene. Life Sci. 151:339–347. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anders S and Huber W: Differential
expression analysis for sequence count data. Genome Biol.
11:R1062010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang DW, Sherman BT, Tan Q, Kir J, Liu D,
Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC and Lempicki RA:
DAVID Bioinformatics Resources: Expanded annotation database and
novel algorithms to better extract biology from large gene lists.
Nucleic Acids Res. 35:W169–W175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dweep H, Sticht C, Pandey P and Gretz N:
miRWalk-database: Prediction of possible miRNA binding sites by
‘walking’ the genes of three genomes. J Biomed Inform. 5:839–847.
2011. View Article : Google Scholar
|
|
17
|
Chou CH, Shrestha S, Yang CD, Chang NW,
Lin YL, Liao KW, Huang WC, Sun TH, Tu SJ, Lee WH, et al: miRTarBase
update 2018: A resource for experimentally validated
microRNA-target interactions. Nucleic Acids Res. 46:D296–D302.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xing Y, Zhang J, Lu L, Li D, Wang Y, Huang
S, Li C, Zhang Z, Li J and Meng A: Identification of hub genes of
pneumocyte senescence induced by thoracic irradiation using
weighted gene coexpression network analysis. Mol Med Rep.
13:107–116. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Subudhi AK, Boopathi PA, Pandey I, Kaur R,
Middha S, Acharya J, Kochar SK, Kochar DK and Das A: Disease
specific modules and hub genes for intervention strategies: A
co-expression network based approach for Plasmodium falciparum
clinical isolates. Infect Genet Evol. 35:96–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich R, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong QY, Wu GM, Qian GS, Hu CP, Zhou JY,
Chen LA, Li WM, Li SY, Wang K, Wang Q, et al: Prevention and
management of lung cancer in China. Cancer. 121 (Suppl
17):S3080–S3088. 2015. View Article : Google Scholar
|
|
24
|
Al-Rakan MA, Hendrayani SF and Aboussekhra
A: CHEK2 represses breast stromal fibroblasts and their paracrine
tumor-promoting effects through suppressing SDF-1 and IL-6. BMC
Cancer. 16:5752016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, McKay JD, Rafnar T, Wang Z,
Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, et al:
Rare variants of large effect in BRCA2 and CHEK2 affect risk of
lung cancer. Nat Genet. 46:736–741. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Siołek M, Cybulski C, Gąsior-Perczak D,
Kowalik A, Kozak-Klonowska B, Kowalska A, Chłopek M, Kluźniak W,
Wokołorczyk D, Pałyga I, et al: CHEK2 mutations and the risk of
papillary thyroid cancer. Int J Cancer. 137:548–552. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leedom TP, LaDuca H, McFarland R, Li S,
Dolinsky JS and Chao EC: Breast cancer risk is similar for CHEK2
founder and non-founder mutation carriers. Cancer Genet.
209:403–407. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nquyen MH, Ueda K, Nakamura Y and Daigo Y:
Identification of a novel oncogene, MMS22L, involved in lung and
esophageal carcinogenesis. Int J Oncol. 4:1285–1296. 2012.
|
|
29
|
Piwko W, Mlejnkova LJ, Mutreja K, Ranjha
L, Stafa D, Smirnov A, Brodersen MM, Zellweger R, Sturzenegger A,
Janscak P, et al: The MMS22L-TONSL heterodimer directly promotes
RAD51-dependent recombination upon replication stress. EMBO J.
35:2584–2601. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen X, Tong ZK and Zhou JY, Yao YK, Zhang
SM and Zhou JY: MicroRNA-206 inhibits the viability and migration
of human lung adenocarcinoma cells partly by targeting MET. Oncol
Lett. 12:1171–1177. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen QY, Jiao DM, Yan L, Wu YQ, Hu HZ,
Song J, Yan J, Wu LJ, Xu LQ and Shi JG: Comprehensive gene and
microRNA expression profiling reveals miR-206 inhibits MET in lung
cancer metastasis. Mol Biosyst. 11:2290–2302. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Su TJ, Ku WH, Chen HY, Hsu YC, Hong QS,
Chang GC, Yu SL and Chen JJ: Oncogenic miR-137 contributes to
cisplatin resistance via repressing CASP3 in lung adenocarcinoma.
Am J Cancer Res. 6:1317–1330. 2016.PubMed/NCBI
|
|
33
|
Chang TH, Tsai MF, Gow CH, Wu SG, Liu YN,
Chang YL, Yu SL, Tsai HC, Lin SW, Chen YW, et al: Upregulation of
microRNA-137 expression by Slug promotes tumor invasion and
metastasis of non-small cell lung cancer cells through suppression
of TFAP2C. Cancer Lett. 402:190–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen WJ, Zhang EN, Zhong ZK, Jiang MZ,
Yang XF, Zhou DM and Wang XW: MicroRNA-153 expression and prognosis
in non-small cell lung cancer. Int J Clin Exp Pathol. 8:8671–8675.
2015.PubMed/NCBI
|
|
35
|
Shan N, Shen L, Wang J, He D and Duan C:
MiR-153 inhibits migration and invasion of human non-small-cell
lung cancer by targeting ADAM19. Biochem Biophys Res Commun.
456:385–391. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Boudjadi S, Chatterjee B, Sun W, Vemu P
and Barr FG: The expression and function of PAX3 in development and
disease. Gene. 666:145–157. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Pastuszak-Lewandoska D, Domańska D,
Czarnecka KH, Kordiak J, Migdalska-Sęk M, Nawrot E, Kiszałkiewicz
J, Antczak A, Górski P and Brzeziańska E: Expression of STAT5,
COX-2 and PIAS3 in correlation with NSCLC histhopathological
features. PLoS One. 9:e1042652014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cao S, Yan Y, Zhang X, Zhang K, Liu C,
Zhao G, Han J, Dong Q, Shen B, Wu A and Cui J: EGF stimulates
cyclooxygenase-2 expression through the STAT5 signaling pathway in
human lung adenocarcinoma A549 cells. Int J Oncol. 39:383–391.
2011.PubMed/NCBI
|
|
39
|
Silva FP, Hamamoto R and Nakamura Y:
WDRPUH, a novel WD-repeat-containing protein, is highly expressed
in human hepatocellular carcinoma and involved in cell
proliferation. Neoplasia. 7:348–355. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fagerberg L, Hallström BM, Oksvold P,
Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S,
Danielsson A, Edlund K, et al: Analysis of the human
tissue-specific expression by genome-wide integration of
transcriptomics and antibody-based proteomics. Mol Cell Proteomics.
13:397–406. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Loucks CM, Bialas NJ, Dekkers MP, Walker
DS, Grundy LJ, Li C, Inglis PN, Kida K, Schafer WR, Blacque OE, et
al: PACRG, a protein linked to ciliary motility, mediates cellular
signaling. Mol Biol Cell. 27:2133–2144. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Toma MI, Wuttig D, Kaiser S, Herr A, Weber
T, Zastrow S, Koch R, Meinhardt M, Baretton GB, Wirth MP and
Fuessel S: PARK2 and PACRG are commonly downregulated in clear-cell
renal cell carcinoma and are associated with aggressive disease and
poor clinical outcome. Gene Chromosome Canc. 3:265–273. 2013.
View Article : Google Scholar
|
